Diagnosis at an early stage of the disease is a prerequisite to take advantage of the time window for optimally effective disease-modifying therapy (DMARD). This not only enables a reduction in pain and inflammation, but can also halt progressive joint destruction and associated functional limitations. Disease activity can be objectified using the DAS28 score.